Seoul, South Korea

Kyeong Seok Park

This inventor holds 4 USPTO granted patents. Top assignee: I-Sens, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyeong Seok Park. Retrieved from https://idiyas.com/inventor/kyeong-seok-park-t3phjpjt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kyeong Seok Park: Innovator in Blood Glucose Measurement Technology

Introduction

Kyeong Seok Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical technology, particularly in the area of blood glucose monitoring. With a total of 4 patents to his name, Park is recognized for his innovative solutions that enhance the quality of life for individuals with diabetes.

Latest Patents

Among his latest patents are the Continuous Blood Glucose Measurement Sensor and the Applicator for a Continuous Blood Glucose Measurement Sensor. These inventions represent a leap forward in the accuracy and convenience of glucose monitoring, allowing for real-time data collection and improved management of diabetes.

Career Highlights

Kyeong Seok Park is currently employed at I-Sens, Inc., a company dedicated to developing advanced medical devices. His work at I-Sens has positioned him as a key player in the medical technology sector, where he continues to push the boundaries of innovation.

Collaborations

Park has collaborated with notable colleagues, including Won Seok Choi and Hyun Ho Choi. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Kyeong Seok Park's contributions to blood glucose measurement technology exemplify the impact of innovation in healthcare. His work not only advances medical technology but also improves the lives of countless individuals managing diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…